etoposide phosphate
etoposide phosphate is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including ETOPOPHOS. Available dosage form: injection, powder, lyophilized, for solution.
Drug Details
- Generic Name
- etoposide phosphate
- Brand Names
- ETOPOPHOS
- Application Number
- NDA020457
- Sponsor
- H2-Pharma, LLC
- NDC Codes
- 1
- Dosage Forms
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- ETOPOSIDE PHOSPHATE
Indications and Usage
1 INDICATIONS AND USAGE ETOPOPHOS is a topoisomerase inhibitor indicated for the treatment of patients with: Refractory testicular tumors, in combination with other chemotherapeutic drugs. ( 1 ) Small cell lung cancer, in combination with cisplatin, as first-line treatment. ( 1 ) 1.1 Refractory Testicular Tumors ETOPOPHOS is indicated, in combination with other chemotherapeutic drugs, for treatment of patients with refractory testicular tumors. 1.2 Small Cell Lung Cancer ETOPOPHOS is indicated, in combination with cisplatin, for first-line treatment of patients with small cell lung cancer.